Sequence Bio ^Companies

Sequence Bio is an organization focused on discovering the true signals of disease in order to develop life-changing medicines. With the goal of improving the success rate of drug candidates, which currently stands at 90%, Sequence Bio aims to accelerate the development of treatments for those in need. They leverage the unique genetic diversity found in the Newfoundland population, known as the founder effect, to identify better drug targets. Through their innovative approach, Sequence Bio aims to revolutionize drug discovery and make a significant impact on healthcare outcomes.